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Abstract 
Two-stage reconstruction using an antibiotic loaded cement spacer is the preferred treat-
ment method of late hip joint infections. Hip spacers maintain stability of the joint and length 
of the limb during treatment period. However, as the material strength of bone cement 
(PMMA) is limited, spacer fractures led to serious complications in the past. This study in-
vestigated the load capacity of custom made hip spacers, developed at the ‘Klinik für Or-
thopädie und Orthopädische Chirurgie’ (Universitätsklinikum des Saarlandes, Homburg / 
Saar, Germany), and implanted into composite femurs. In a quasi-static test, non-reinforced 
spacers tolerated hip joint loads of about 3000 N, whereas reinforced spacers with tita-
nium-grade-two endoskeletons doubled this load up to 6000 N. Even for cyclic loading, 
endoskeleton-including hip spacers tolerated loads of >4500 N with 500,000 load cycles. 
Thus, an endoskeleton-including spacer should provide a mobile and functional joint through 
the treatment course. A generated FE-model was used to determine the fracture stresses 
and allows for further sensitivity analysis. 
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Introduction 
The application of a spacer made of antibiotic 
impregnated bone cement (PMMA) is a recom-
mended treatment method in the two-stage reim-
plantation procedure for late hip joint infections [1-5]. 
An antibiotic-impregnated cement spacer delivers a 
high-dose concentration of local antibiotics to the in-
fected area, prevents soft tissue shortening and pro-
vides better function than a resection arthroplasty. 
Although few commercially made, pre-formed hip 
spacers are available, they lack adaptability [6, 7]. The 
‘Klinik für Orthopädie und Orthopädische Chirurgie’ 
(Universitätsklinikum des Saarlandes, Homburg / 
Saar, Germany) developed therefore a special 
moulding form whereby a standardized, antibi-
otic-loaded cement spacer adapted to patient infection 
can be formed during surgery [8-10]. As spacers are 
capable to eradicate the infections, complications in-
clude fractures of spacers [11-13]. This study evaluates 
therefore the strength of non-reinforced spacers and 
spacers having an adapted endoskeleton when im-
planted into composite femurs.  
Materials and Methods 
Laboratory test 
The bone cement Palacos® (Merck, Darmstadt, 
Germany) was used for our spacers. It is distin-
guished because of its very high antibiotic release rate Int. J. Med. Sci. 2009, 6 
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with comparative high material strength [14-16]. To 
form a single spacer (head diameter, 50 mm; stem 
length, 100 mm; surface area, 13,300 mm
2), a mixture 
o f  8 0  g  p o w d e r  i n t o  4 0  m l  l i q u i d  w a s  h a n d  m i x e d  
without vacuum. In order to keep variety as low as 
possible, plain cement, i.e. cement without antibiotic 
has been used for mechanical testing. Spacer were 
formed into a 2-parts molding form out of polyoxy-
methylene (POM) [17] (Fig.1). After filling but before 
consolidation, an endoskeleton made of tita-
nium-grade-two (Euro-Titan AG, Solingen, Germany) 
could be centered into the cement spacer for rein-
forcement (Fig. 2). 
 
 
 
 
 
  
 
 
 
 
 
Figure 1: Two components of Palacos®: powder (poly-
mer) and liquid (monomer) are mixed in a ratio of 2g : 1ml. 
After mixing, the compound is filled into a casting mould of 
polyoxymethylene (POM) to form the spacer.  
 
 
 
Figure 2: Spacer with endoskeleton of titanium-grade-two 
and distance pieces for centering 
 
Titanium grade two was chosen because of its 
biocompatibility, very high strength and ductility. For 
testing, non-reinforced and reinforced spacers were 
implanted into fourth generation composite femurs 
(Sawbones AB, Malmö, Sweden) that had the femoral 
head removed and canal reamed. As there is no 
standardized protocol of testing the mechanical be-
haviour of a hip spacer available, the loading proce-
dure was defined following the recommendations of 
the ISO 7206 standard for determination of fatigue 
performance of hip stems [18]. The femurs were in-Int. J. Med. Sci. 2009, 6 
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clined 10° in the frontal plane and 9° in the sagittal 
plane and loaded using an INSTRON servo-hydraulic 
testing machine (Instron, Darmstadt, Germany). 
Loads are applied through the femoral head of the 
spacer, where shear loads were eliminated by means 
of a ball bearing cup (Fig. 3).  
 
 
Figure 3: Test bed for an implanted spacer in a composite 
femur on a servo-hydraulic cylinder test station (Instron, 
PL10K). The femur is oriented at 9° in the sagittal plane and 
10° in the frontal plane. 
 
To keep friction as low as possible, the interface 
between cup (POM, d = 120 mm) and spacer head 
(PMMA) is furthermore lubricated (Shell 138 Retinax 
CS 00). The loading rate of the quasi-static test was 20 
N/s. Cyclical tested spacers were sinusoidally loaded 
with a frequency of 5 Hz. Test abort was either failure 
of the spacer or the femur. Three specimens were 
tested in each test series.  
Finite element model 
Based on the laboratory tests, a finite element 
model of spacer and femur was developed to analyze 
stresses. The analysis was performed using ANSYS, a 
FEA software (ANSYS Inc., Canonsburg, United 
States). The standardized femur was used as a basis 
for a finite element model of a composite femur [19]. 
An IGES file of the spacer with/without endoskeleton 
was placed within the composite femur geometry. 
Meshing was conducted by the element 186, a hexa-
hedral solid element with quadratic displacement 
behaviour (Fig. 4). For modeling the contact and 
sliding between femur-spacer interface, CONTACT 
174 and TARGET 170 elements were used. The mate-
rial properties are given in Table 1. The femur is 
separated into two materials, cortical and cancellous 
bone. The bone materials were assumed to be iso-
tropic and homogeneous (Table 1).  
Table 1: List of material properties used for the analysis 
Tension   
Material 
 
Young’s 
modulus
 
[MPa] 
Poisson’s 
ratio (ν) 
  Yield 
strength 
[MPa] 
Ultimate 
strength
[MPa] 
Compression
strength 
 
[MPa] 
Cortical 
bone 
16,000 0.26  -  107  154 
Cancellous 
bone 
150 0.30 -  -  - 
PMMA 2,500 0.35  -  35  85-100 
Titanium 
grade 2 
110,000 0.34  Rp0,2=325 430  430 
 
 
Loading is similar to the laboratory tests, muscle 
forces affecting the strain distribution on the femur 
were neglected. The resultant hip force FR on the head 
of the spacer can be resolved into: 
Fx = -cos 9° · sin 10° · FR = -0.17 · FR 
Fy = -sin 9° · FR = -0.16 · FR 
Fz = -cos 9° · cos 10° · FR = -0.97 · FR 
 
 
 
Figure 4: Finite element model of the spacer and femur 
with meshing conducted by the solid element 186. Int. J. Med. Sci. 2009, 6 
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Results 
Laboratory test 
Non-reinforced spacers, implanted into compos-
ite femur and quasi-static tested failed at FR = 2935 ± 
322 N (Fig. 5). Spacer fracture occurred between 65 – 
75 mm proximal to the spacer tip with the stem re-
maining in the medullary canal. Mechanical spalling 
of a bone edge and tears on the proximal femur could 
be observed after testing.  
Spacers with an endoskeleton sustained loads up 
to FR = 6270 ± 772 N and thus doubled the initial load 
of non-reinforced spacers. Thereby loads exceeding 
5000 – 6000 N caused a non-linear displacement be-
haviour of the reinforced spacer and resulted into 
periprosthetic fractures of the proximal part of the 
femur (Fig. 6). Fracture was of explosion type where 
the spacer is loose and the fracture is inherently un-
stable. Reinforced spacer, cyclical loaded with 500,000 
load cycles per load level could even resist maximum 
loads between FR = 4700 – 4900 N before failure (Table 
2).  
 
 
 
 
 
 
Figure 5: Force – Displacement curves for the three non-reinforced spacers, quasi-static tested  
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Figure 6: Force – Displacement curves for the three endoskeleton including spacers, quasi-static tested 
 
 
 
 
 
 
Table 2: Results of three endoskeleton-including spacers 
tested cyclically at different load ranges until fracture 
  lower cycle load - 
upper cycle load [N] 
load cycles  condition 
300 – 4500  500,000  passed  Femur 1 
300 – 4700  83,000  failure 
300 – 4500  500,000  passed 
300 – 4700  500,000  passed 
Femur 2 
300 – 4900  47,000  failure 
300 – 4500  500,000  passed 
300 – 4700  500,000  passed 
Femur 3 
300 – 4900  156,000  failure 
 
 
Finite element model 
The locations where the maximum stresses occur 
on femur and spacer, respectively, are in accordance 
to the fractures within the laboratory tests. The 
maximum equivalent stresses on a non-reinforced 
spacer reached the breakage stress (bending strength 
of Palacos®: 50-60 MPa) at about FR = 3000 N (Fig. 7a). 
In case of a reinforced spacer, the stresses are distrib-
uted according to the material stiffnesses, and, hence, 
the endoskeleton carries the main load. The yield 
strength of the titanium endoskeleton (325 MPa) is 
reached at a hip joint load of FR = 5000 N (Fig. 7b). 
However, as titanium-grade-two is a quite ductile 
material, there are still plastic material reserves 
available. The peak stresses on the femur located 
above the lesser trochanter produce stress values of 
120 MPa and 153 MPa, respectively, and should be 
considered to indicate damage initiation events of 
periprothetic fracture.   
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Figure 7: Equivalent von Mises stress distribution. a) 
non-reinforced spacer at FR = 3000 N; b) endoskeleton 
including spacer at FR = 5000 N 
Discussion 
As shown, non-reinforced spacers are signifi-
cantly weaker than endoskeleton-including hip spac-
ers. A previous study determined the quasi-static 
breaking load for non-reinforced hip spacers by 800 - 
1000 N, in case that 60 mm of the stem length is em-
bedded into polyurethane [12]. Compared to the for-
mer study, loads could be significantly increased by 
changing the boundary conditions from a more con-
servative approximation to a fixation where the distal 
and proximal parts of the spacer-stem are supported 
by using a composite femur. The suitability of the 
composite femur has been demonstrated by Cristofo-
lini et al. [20] who showed that no significant differ-
ences in mechanical behaviour were found between 
composite femora and two groups of cadaveric 
specimens, while the inter-femur variability for the 
composite femur is highly reduced. Considering a hip 
resultant force of 3-4 times body weight during 
walking [21, 22], non-reinforced spacer can possibly 
withstand the loads if conditions are ideal. Neverthe-
less, fracture occurred occasionally on non-reinforced 
spacers, even if the proximal femur was in good con-
dition [11]. The influence of cement porosity may 
dominate the effect of the stress to a degree that fail-
ure may occur earlier at lower stress levels as well 
[16]. Washed out antibiotics increases the number of 
pores and reduces the strength as well [16]. However 
this effect is negligible for endoskeleton including 
spacers and the use of plain cement, i.e. Palacos® 
without antibiotic, for mechanical evaluation won’t 
influence the result much [12]. Regarding cyclic 
loading, spacers with titanium endoskeleton can even 
bear up a maximum hip resultant force of 4900 N 
when loaded with 500,000 load cycles. On the as-
sumption that one million load cycles is the average 
yearly load history for a healthy person and that the 
spacer remains in situ for no longer than six month, 
0.5 million cycles is the upper limit the spacer will 
ever be charged with [22, 23].  
Clinical trial has shown that for antibiotic im-
pregnated bone cements the major elution of antibi-
otics is just within the outer 2-3 mm, thus the endo-
skeleton won’t influence the treatment adversely [11]. 
Moreover, as the existing endoskeleton carries the 
main load, the porosity of the cement coating may be 
increased which increases the antibiotic elution as 
well [15]. Anagnostakos et al. [24] showed a consid-
erably increase in elution of commercially added 
gentamicin for spacers containing a metallic endo-
skeleton, whereas the elution of linezolid was mar-
ginally reduced. Antibiotic release behavior is mainly 
influenced by relative loading amount, porosity, sur-
face area and surface roughness of the bone cement 
[25-28].  
Beyond the here presented results, the devel-
oped FE-model can be further used for sensitive 
analysis. Hence, altering circumstances can initially be 
simulated on computer before starting expensive test 
series.  
As the treatment of hip infections is usually 
necessary on elderly people where the bone density 
may be reduced, further biomechanical studies to 
investigate the dynamic properties of hip spacers im-
planted into cadaver femurs of elderly persons (age > 
60 years) have started.  Int. J. Med. Sci. 2009, 6 
 
http://www.medsci.org 
286
Conclusion 
Intraoperatively formed spacers by means of a 
moulding form gives the possibility of customizing 
the antibiotic contained in the cement and insert an 
adapted endoskeleton. Present clinical experience and 
mechanical studies showed that spacers with an en-
doskeleton are well adapted to eradicate hip-infection 
and withstand normal loading during walking. Thus 
full-weight bearing is possible with this system, but 
restriction may be due to the condition of the femur. 
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